CRYSTAL ENGLERT: Open Payments
NPI 1609861533 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 76 payments from 14 companies in 2025. Trend: 2023 $788 · 2024 $1,164 · 2025 $1,006
Food & beverage: $997Education: $10
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $175 |
| UCB, Inc. | 7 | $163 |
| Novartis Pharmaceuticals Corporation | 29 | $143 |
| ABBVIE INC. | 14 | $141 |
| Lilly USA, LLC | 4 | $94 |
| Janssen Biotech, Inc. | 3 | $82 |
| Amgen Inc. | 2 | $46 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Organon LLC | 1 | $29 |
| Genentech USA, Inc. | 1 | $23 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, COSENTYX, TALTZ, TREMFYA, OTEZLA, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
